scholarly journals Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease

2010 ◽  
Vol 26 (1) ◽  
pp. 392-392
Author(s):  
Y.-C. Tsai ◽  
C.-C. Hung ◽  
S.-J. Hwang ◽  
S.-L. Wang ◽  
S.-M. Hsiao ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease

2009 ◽  
Vol 25 (5) ◽  
pp. 1621-1626 ◽  
Author(s):  
Y. C. Tsai ◽  
C. C. Hung ◽  
S. J. Hwang ◽  
S. L. Wang ◽  
S. M. Hsiao ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Quality of Care in Chronic Kidney Disease and Incidence of End-Stage Renal Disease in Older Patients

Medical Care ◽  
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Shingo Fukuma ◽  
Tatsuyoshi Ikenoue ◽  
Sayaka Shimizu ◽  
Edward C. Norton ◽  
Rajiv Saran ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Quality Of Care ◽  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Older Patients ◽  
Stage Renal Disease ◽  
End Stage

Impact of First Dialysis Modality on Outcome of Patients Contraindicated for Kidney Transplant

2006 ◽  
Vol 26 (2) ◽  
pp. 231-239 ◽  
Author(s):  
Luc Frimat ◽  
Pierre-Yves Durand ◽  
Carole Loos–Ayav ◽  
Emmanuel Villar ◽  
Victor Panescu ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Kidney Disease ◽  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Role Limitation ◽  
Stage Renal Disease ◽  
End Stage ◽  
Incident Cases

Background We compared, in patients contraindicated for kidney transplant, outcomes between those patients who were only on hemodialysis (HD) and those who were given peritoneal dialysis (PD) as first renal replacement therapy (RRT). Design Prospective, population-based cohort study of incident cases of end-stage renal disease between June 1997 and June 1999. Setting A network of dialysis care: NEPHROLOR, that is, all the renal units in Lorraine, one of the 22 French administrative regions (population over 2.3 million people). Participants 387 patients were contraindicated for kidney transplant during the first 2 years of RRT: 284 were on HD, 103 on PD. Mean age was 67.6 ± 11.3 years for HD patients and 70.8 ± 11.4 years for PD patients ( p = 0.015). Main Outcome Measures Mortality until June 2003, hospitalization over the 2 first years of RRT, and Kidney Disease and Quality of Life Short Form (KDQOL-SF) 6 and 12 months after initiation of RRT. Results HD patients were more likely to die from cardiac or cerebrovascular causes, PD from cachexia or withdrawal from dialysis. Whatever mode of RRT, the unadjusted 2-year and 5-year survival rates were similar ( p = 0.98). The rate of total duration of hospital stay per month of RRT was similar in HD and PD groups: 2.7 ± 4.5 and 2.9 ± 4.2 days respectively ( p = 0.7). PD was associated with better quality of life than HD. The dimensions Role limitation due to emotional function, Burden of kidney disease, and Role limitation due to physical function ranked first, second, and third for PD. Conclusion In Lorraine, end-stage renal disease patients who were given PD as first-line RRT had no excess of death risk or hospitalizations, and better quality of life the first year of RRT.

KUALITAS HIDUP PASIEN GAGAL GINJAL KRONIS YANG MENJALANI HEMODIALISIS DI RSUD CHASAN BOESOIRIE TERNATE

2019 ◽  
Vol 1 (2) ◽  
Author(s):  
FATHUL RISKY
Keyword(s):  
Quality Of Life ◽  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Short Form ◽  
Primary Data ◽  
P Value ◽  
Stage Renal Disease ◽  
End Stage

Introduction. Chronic kidney disease (CKD) as a result of structural and functional renal failure has a high progressivity leading to an end stage renal disease (ESRD), thus a therapy is needed to replace the renal function such as hemodialysis. Long term hemodialysis therapy affects many aspects of life and degrading the quality of life of the patient. Method. This cross-sectional study was conducted at Chasan Boesoirie Hospital, Ternate. Primary data, such as socio-demography were taken through history taking and medical records. Quality of life was assessed using Kidney Disease Quality of Life - Short Form (KDQOL-SF)-36 TM which has been used to measure quality of life of patients undergoing hemodialysis. Results. From this study a sample of 77 patients was obtained, of which 41 were male (53.25%) and 36 were female (46.75%). Of the three quality of life components assessed, KDCS components were 78.65 ± 13.39; the MCS component 54.67 ± 7.53; and PCS components 42.47 ± 7.76. Conclusions. From the results of the study it was found that the highest KDQOL-36TM score was obtained for the kidney disease component (KDCS), then the mental health component (MCS), and the lowest score for the physical health component (PCS). Of all the variables hypothesized to affect the quality of life of kidney failure patients undergoing hemodialis, not a single variable was found to be significantly affected (P value> 0.05).Keywords: end-stage renal disease, hemodialysis, quality of life.

Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs

Nephrology ◽  
2010 ◽  
Vol 15 (1) ◽  
pp. 108-115 ◽  
Author(s):  
SHU-YI WEI ◽  
YONG-YUAN CHANG ◽  
LIH-WEN MAU ◽  
MING-YEN LIN ◽  
HERNG-CHIA CHIU ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Care Program ◽  
Medical Costs ◽  
Chronic Kidney Disease Care ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals NURSE-LED INTERVENTION TO IMPROVE THE QUALITY OF LIFE AMONG ADULTS WITH TYPE 2 DIABETES UNDERGOING HEMODIALYSIS

2018 ◽  
Vol 10 (1) ◽  
Author(s):  
Melba Sheila D’Souza ◽  
Ramesh Venkatesaperumal ◽  
Jennifer Walden ◽  
Pramod Kamble
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Control Group ◽  
Stage Renal Disease ◽  
End Stage

Aim: Chronic kidney disease is a progressive decline in renal function with a reduced glomerular filtration rate and proteinuria. The study evaluates the nurse-led intervention to improve the quality of life among adults with type 2 diabetes on hemodialysis.Methods: The study was a randomized controlled trial with a pre-test and post-test in a tertiary hospital. A random sample of 110 adults with type 2 diabetes (T2D) and end-stage renal disease (ESRD) in the intervention and 100 adults in the control group was selected for the study in 2017. General linear model and Repeated measures were done to determine the effects of thegroup. Results: A statistically significant main effect (between-groups), within-group (time) and interaction effects for intervention were detected in all the parameters across time from T2 to T3 in the intervention group. Conclusion: Nurse-led intervention had a positive effect on the kidney disease, physical and mental health among the adults with T2D and end-stage renal disease.

scholarly journals Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis

Diagnostics ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. 245 ◽  
Author(s):  
Laura Cotoi ◽  
Florin Borcan ◽  
Ioan Sporea ◽  
Daniela Amzar ◽  
Oana Schiller ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Thyroid Disease ◽  
Nodular Goiter ◽  
Thyroid Stimulating Hormone ◽  
Stage Renal Disease ◽  
End Stage

Objectives: Chronic kidney disease is a rising cause of morbidity and mortality in developed countries, including end-stage renal disease (ESRD). The prevalence of thyroid comorbidities in persons with chronic kidney disease is documented higher than in normal population. The study aims to investigate the prevalence of morphological and functional thyroid disorders in patients with chronic kidney disease, with renal replacement therapy (hemodialysis). Methods: A cross-sectional study was performed on 123 consecutive patients with chronic kidney disease stage 5, on hemodialysis during a period of one month (May 2019–June 2020). All patients were enrolled for maintenance hemodialysis in B Braun Hemodialysis Center Timisoara and were examined on conventional 2B ultrasound. Thyroid blood tests were done, including serum free thyroxin (FT4), free triiodothyronine (FT3) and thyroid-stimulating hormone (TSH) at the time of starting hemodialysis. Results: We evaluated 123 patients (male to female ratio 70/53) mean age 62.2 ± 11.01, mostly above 65 years old, enrolled in the end-stage renal disease program, on renal replacement therapy. From the cohort, 76/123 presented thyroid disease, including autoimmune hypothyroidism, nodular goiter or thyroid cancer. Among them, 63 patients presented nodular goiter, including 3 thyroid cancers, confirmed by surgery and histopathological result, 22 patients had thyroid autoimmune disease. The serum thyroid-stimulating hormone levels found in the cohort was 3.36 ± 2.313 mUI/mL, which was in the normal laboratory reference range. The thyroid volume was 13 ± 7.18 mL. A single patient in the cohort presented Graves Basedow disease, under treatment and three patients present subclinical hyperthyroidism. We have found that thyroid disease risk is increased by 3.4-fold for the female gender and also the increase of body mass index (BMI) with one unit raises the risk of developing thyroid disease with 1.083 times (p = 0.018). Conclusion: To conclude, this study aimed to quantify the prevalence of thyroid disease in end-stage kidney disease population, especially nodular goiter, important for differential diagnosis in cases with secondary hyperparathyroidism. Thyroid autoimmune disease can be prevalent among these patients, as symptoms can overlap those of chronic disease and decrease the quality of life. We have found that thyroid disease has a high prevalence among patients with end-stage renal disease on hemodialysis. Thyroid goiter and nodules in ESRD patients were more prevalent than in the general population. Clinical surveillance and routine screening for thyroid disorders can improve the quality of life in these patients.

Sign in / Sign up

Export Citation Format

Share Document